(Q26851255)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

Cancer concepts and principles: primer for the interventional oncologist-part I (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Ryan Hickey

1

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Michael Vouche

2

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Elias Hohlastos

4

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Jeremy Collins

5

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Todd Schirmang

6

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Khairuddin Memon

7

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Kent Sato

9

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Richard Chen

10

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Ramona Gupta

11

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Scott Resnick

12

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

James Carr

13

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Daniel Y Sze

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Robert K Ryu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Howard B Chrisman

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Albert A Nemcek

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Robert L Vogelzang

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Robert J Lewandowski

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

language of work or name

1 reference

25 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

Journal of Vascular and Interventional Radiology

4 March 2020

published in

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

24

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

8

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

1157-1164

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

Randomisation to protect against selection bias in healthcare trials

4 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800037

What is meant by intention to treat analysis? Survey of published randomised controlled trials

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800037

Sorafenib in advanced hepatocellular carcinoma

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800037

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800037

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800037

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800037

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800037

Reporting results of cancer treatment

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800037

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800037

Investigator-initiated trials of targeted oncology agents: why independent research is at risk?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800037

Overall survival: a gold standard in search of a surrogate: the value of progression-free survival and time to progression as end points of drug efficacy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800037

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800037

Design and endpoints of clinical trials in hepatocellular carcinoma.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800037

Endpoints for assessing drug activity in clinical trials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800037

End points for adjuvant therapy trials: has the time come to accept disease-free survival as a surrogate end point for overall survival?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800037

Is overall survival a realistic primary end point in advanced colorectal cancer studies? A critical assessment based on four clinical trials comparing fluorouracil plus leucovorin with the same treatment combined either with oxaliplatin or with CPT-

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800037

One and two sided tests of significance

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800037

The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800037

P-value interpretation and alpha allocation in clinical trials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800037

Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800037

Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable?

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800037

The 2 "Es" of research: efficacy and effectiveness trials.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800037

Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging

28 November 2018

1 reference

12 December 2020

Survival is not a good outcome for randomized trials with effective subsequent therapies.

1 reference

12 December 2020

Evaluation of treatment response of chemoembolization in hepatocellular carcinoma with diffusion-weighted imaging on 3.0-T MR imaging

1 reference

12 December 2020

Assessment of liver tumor response by high-field (3 T) MRI after radiofrequency ablation: short- and mid-term evolution of diffusion parameters within the ablation zone

1 reference

12 December 2020

Role of magnetic resonance diffusion-weighted imaging in evaluating response after chemoembolization of hepatocellular carcinoma

1 reference

12 December 2020

10.1016/J.JVIR.2013.04.024

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23809510%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

PubMed publication ID

2 references